高级检索
当前位置: 首页 > 详情页

Treatment with Quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell cycle arrest

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Guangdong-Hong Kong Joint Laboratory for Immunological and Genetic Kidney Diseases, Departments of Nephrology and Pathology, Guangdong Provincial People’sHospital, Guangdong Academy of Medical Science, Guangzhou, China [2]Departments of Medicine & Therapeutics, Li Ka Shing Institute of Health Sciences, Lui Che WooInstitute of Innovative Medicine, and The Chinese University of Hong Kong (CUHK) - Guangdong Academy of Medical Sciences/Guangdong Provincial People’s Hospital(GAMS/GPPH) Joint Research Laboratory on Immunological and Genetic Kidney Diseases, The Chinese University of Hong Kong, Hong Kong, China [3]Hubei Universityof Chinese Medicine, Wuhan, China [4]Department of Nephrology, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of TraditionalChinese Medicine, Wuhan, China [5]Department of Nephrology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China
出处:
ISSN:

摘要:
Increasing evidence shows that SARS-CoV-2 can infect kidneys and cause acute kidney injury (AKI) in critically ill COVID-19 patients. However, mechanisms through which COVID-19 induces AKI are largely unknown and treatment remains no-effective. Here, we report that kidney-specifically overexpressing SARS-CoV-2 N gene can cause AKI including tubular necrosis and elevated levels of serum creatinine and BUN in 8-week-old diabetic db/db mice, which become worse in those with older age (16 weeks) and underlying diabetic kidney disease (DKD).Treatment with quercetin, a purified product from the traditional Chinese medicine (TCM) that shows effective treatment of COVID-19 patients, can significantly inhibit SARS-CoV-2 N protein-induced AKI in diabetic mice with or without underlying DKD. Mechanistically, quercetin can block the binding of SARS-CoV-2 N protein to Smad3, thereby inhibiting Smad3 signaling and Smad3-mediated cell death via the p16-dependent G1 cell cycle arrest mechanism in vivo and vitro. In conclusion, SARS-CoV-2 N protein is pathogenic and can cause severe AKI in diabetic mice, particularly in those with older age and pre-existing DKD, via the Smad3-dependent G1 cell cycle arrest mechanism. Importantly, we identify that quercetin may be an effective TCM compound capable of inhibiting COVID-19 AKI by blocking SARS-CoV-2 N-Smad3-mediated cell death pathway.Copyright © 2022 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 1 区 医学
小类 | 1 区 遗传学 1 区 生物工程与应用微生物 1 区 医学:研究与实验
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 生物工程与应用微生物 1 区 遗传学 1 区 医学:研究与实验
JCR分区:
出版当年[2021]版:
Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q1 GENETICS & HEREDITY Q1 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q1 GENETICS & HEREDITY Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Guangdong-Hong Kong Joint Laboratory for Immunological and Genetic Kidney Diseases, Departments of Nephrology and Pathology, Guangdong Provincial People’sHospital, Guangdong Academy of Medical Science, Guangzhou, China [2]Departments of Medicine & Therapeutics, Li Ka Shing Institute of Health Sciences, Lui Che WooInstitute of Innovative Medicine, and The Chinese University of Hong Kong (CUHK) - Guangdong Academy of Medical Sciences/Guangdong Provincial People’s Hospital(GAMS/GPPH) Joint Research Laboratory on Immunological and Genetic Kidney Diseases, The Chinese University of Hong Kong, Hong Kong, China [3]Hubei Universityof Chinese Medicine, Wuhan, China [4]Department of Nephrology, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of TraditionalChinese Medicine, Wuhan, China
通讯作者:
通讯机构: [1]Guangdong-Hong Kong Joint Laboratory for Immunological and Genetic Kidney Diseases, Departments of Nephrology and Pathology, Guangdong Provincial People’sHospital, Guangdong Academy of Medical Science, Guangzhou, China [2]Departments of Medicine & Therapeutics, Li Ka Shing Institute of Health Sciences, Lui Che WooInstitute of Innovative Medicine, and The Chinese University of Hong Kong (CUHK) - Guangdong Academy of Medical Sciences/Guangdong Provincial People’s Hospital(GAMS/GPPH) Joint Research Laboratory on Immunological and Genetic Kidney Diseases, The Chinese University of Hong Kong, Hong Kong, China [3]Hubei Universityof Chinese Medicine, Wuhan, China [4]Department of Nephrology, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of TraditionalChinese Medicine, Wuhan, China [*1]Department of Nephrology, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of Traditional Chinese Medicine, Wuhan, China [*2]Guangdong Academy of Medical Science, Guangdong Provincial People’s Hospital, Guangzhou, China. [*3]Departments of Medicine & Therapeutics, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号